Funded Project Details - FY2021
|Title:|| The Role of Deoxysphingolipids in Peripheral Neuropathy|
|Congressional District Code:
||Biomedical Laboratory R&D
|| October 2017 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
There are an estimated 20 million people in the United States who have some form of peripheral neuropathy. Peripheral neuropathy also is the most prevalent complication of both type 1 and type 2 diabetes and affects approximately 60 to 70 percent of patients with diabetes. Clinically, diabetic neuropathy exhibits a pronounced similarity to the neuropathy of patients with hereditary sensory and autonomic neuropathy type 1 (HSAN1). HSAN1 patients exhibit elevated plasma levels of a newly identifie...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.